Landscapes / Companies
PT. Prodia Stem Cell Indonesia not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 in Phase 2
Drugs
4
in active trials · 9 in all
Trials
8 active
11 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Cerebral Palsy, Ischemic Stroke and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | Dec 2026Phase 1/2 trial completes | |||
| Next date | Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Cerebral Palsy, Ischemic Stroke and 2 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 20 Jun 2027Phase 1/2 trial completes | |||
| Next date | 20 Jun 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Liver Cirrhoses | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Nasopharyngeal Cancer | ||||
| Open drug page | |||||
About
- No active trial
- Arthroscopy, Mesenchymal Stem Cells, Non Arthroscopy, UC-MSCs, UC-MSCs and Secretomes
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021